REVS vs. CDC
Compare and contrast key facts about Columbia Research Enhanced Value ETF (REVS) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC).
REVS and CDC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. REVS is a passively managed fund by Ameriprise Financial that tracks the performance of the Beta Advantage Research Enhanced U.S. Value Index. It was launched on Sep 25, 2019. CDC is a passively managed fund by Crestview that tracks the performance of the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. It was launched on Jul 2, 2014. Both REVS and CDC are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
REVS vs. CDC - Performance Comparison
Loading graphics...
REVS vs. CDC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
REVS Columbia Research Enhanced Value ETF | 1.72% | 16.80% | 16.36% | 13.46% | -6.20% | 28.52% | 1.37% | 7.22% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 8.56% | 8.96% | 14.48% | -4.99% | -7.86% | 33.05% | 12.88% | 6.89% |
Returns By Period
In the year-to-date period, REVS achieves a 1.72% return, which is significantly lower than CDC's 8.56% return.
REVS
- 1D
- 0.52%
- 1M
- -3.75%
- YTD
- 1.72%
- 6M
- 5.01%
- 1Y
- 17.19%
- 3Y*
- 15.64%
- 5Y*
- 10.68%
- 10Y*
- —
CDC
- 1D
- -0.43%
- 1M
- -3.49%
- YTD
- 8.56%
- 6M
- 8.44%
- 1Y
- 12.57%
- 3Y*
- 9.47%
- 5Y*
- 6.18%
- 10Y*
- 9.96%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
REVS vs. CDC - Expense Ratio Comparison
REVS has a 0.19% expense ratio, which is lower than CDC's 0.37% expense ratio.
Return for Risk
REVS vs. CDC — Risk / Return Rank
REVS
CDC
REVS vs. CDC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Columbia Research Enhanced Value ETF (REVS) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| REVS | CDC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.06 | 0.93 | +0.13 |
Sortino ratioReturn per unit of downside risk | 1.54 | 1.33 | +0.21 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.19 | +0.03 |
Calmar ratioReturn relative to maximum drawdown | 1.33 | 1.07 | +0.26 |
Martin ratioReturn relative to average drawdown | 5.85 | 4.26 | +1.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| REVS | CDC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.06 | 0.93 | +0.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.72 | 0.49 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.76 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.61 | 0.74 | -0.13 |
Correlation
The correlation between REVS and CDC is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
REVS vs. CDC - Dividend Comparison
REVS's dividend yield for the trailing twelve months is around 2.09%, less than CDC's 3.21% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVS Columbia Research Enhanced Value ETF | 2.09% | 2.13% | 1.89% | 2.49% | 2.46% | 1.18% | 27.75% | 0.70% | 0.00% | 0.00% | 0.00% | 0.00% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 3.21% | 3.36% | 3.32% | 4.24% | 3.48% | 2.65% | 2.48% | 3.04% | 3.37% | 2.81% | 2.99% | 3.17% |
Drawdowns
REVS vs. CDC - Drawdown Comparison
The maximum REVS drawdown since its inception was -37.85%, which is greater than CDC's maximum drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for REVS and CDC.
Loading graphics...
Drawdown Indicators
| REVS | CDC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.85% | -21.37% | -16.48% |
Max Drawdown (1Y)Largest decline over 1 year | -12.35% | -11.27% | -1.08% |
Max Drawdown (5Y)Largest decline over 5 years | -18.04% | -21.37% | +3.33% |
Max Drawdown (10Y)Largest decline over 10 years | — | -21.37% | — |
Current DrawdownCurrent decline from peak | -4.48% | -3.49% | -0.99% |
Average DrawdownAverage peak-to-trough decline | -4.76% | -5.14% | +0.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.81% | 2.82% | -0.01% |
Volatility
REVS vs. CDC - Volatility Comparison
Columbia Research Enhanced Value ETF (REVS) has a higher volatility of 4.18% compared to VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) at 2.81%. This indicates that REVS's price experiences larger fluctuations and is considered to be riskier than CDC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| REVS | CDC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.18% | 2.81% | +1.37% |
Volatility (6M)Calculated over the trailing 6-month period | 8.90% | 7.04% | +1.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.27% | 13.59% | +2.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.93% | 12.56% | +2.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.29% | 13.22% | +6.07% |